These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11434683)

  • 1. Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding.
    Izumi T; Kim SW; Greist A; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH; Ortel TL
    Thromb Haemost; 2001 Jun; 85(6):1048-54. PubMed ID: 11434683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex.
    Nicolaes GA; Villoutreix BO; Dahlbäck B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):89-100. PubMed ID: 10691103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.
    Kim SW; Quinn-Allen MA; Camp JT; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
    Biochemistry; 2000 Feb; 39(8):1951-8. PubMed ID: 10684644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
    Kim SW; Ortel TL; Quinn-Allen MA; Yoo L; Worfolk L; Zhai X; Lentz BR; Kane WH
    Biochemistry; 1999 Aug; 38(35):11448-54. PubMed ID: 10471296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling and expression studies of two novel mutations causing factor V deficiency.
    Delev D; Pavlova A; Heinz S; Blaise MC; Chandra T; Poetsch B; Seifried E; Oldenburg J
    Thromb Haemost; 2008 Nov; 100(5):766-72. PubMed ID: 18989519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations.
    Ortel TL; Moore KD; Quinn-Allen MA; Okamura T; Sinclair AJ; Lazarchick J; Govindan R; Carmagnol F; Kane WH
    Blood; 1998 Jun; 91(11):4188-96. PubMed ID: 9596666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains.
    Pellequer JL; Gale AJ; Griffin JH; Getzoff ED
    Blood Cells Mol Dis; 1998 Dec; 24(4):448-61. PubMed ID: 9880241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of factor VIII inhibitors to discrete regions of the factor VIII C2 domain disrupt phospholipid binding.
    Lewis DA; Moore KD; Ortel TL
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):361-8. PubMed ID: 12945878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of the multimerin 1 binding site in coagulation factor V: an update.
    Jeimy SB; Quinn-Allen MA; Fuller N; Kane WH; Hayward CP
    Thromb Res; 2008; 123(2):352-4. PubMed ID: 18452976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional binding sites for anionic phospholipids and calcium ions in the crystal structures of complexes of the C2 domain of protein kinase calpha.
    Ochoa WF; Corbalán-Garcia S; Eritja R; Rodríguez-Alfaro JA; Gómez-Fernández JC; Fita I; Verdaguer N
    J Mol Biol; 2002 Jul; 320(2):277-91. PubMed ID: 12079385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
    Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
    J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
    Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
    Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis.
    Saleh M; Peng W; Quinn-Allen MA; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
    Thromb Haemost; 2004 Jan; 91(1):16-27. PubMed ID: 14691564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.
    Gilbert GE; Novakovic VA; Kaufman RJ; Miao H; Pipe SW
    Blood; 2012 Aug; 120(9):1923-32. PubMed ID: 22613792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.